Related Experiment Video
Updated: Aug 10, 2026

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
Intrathecal baclofen for generalized dystonia: a case report
1Department of Physical Medicine and Rehabilitation, Southern California Permanente Medical Group, San Diego, CA, USA.
Intrathecal baclofen therapy offers a promising treatment for generalized dystonia unresponsive to conventional therapies. This approach significantly improved patient function, pain, and dystonia severity.
Area of Science:
- Neurology
- Movement Disorders
Background:
- Dystonia involves sustained muscle contractions causing abnormal postures and movements.
- Primary generalized dystonia can become debilitating and resistant to standard treatments like oral medications and physical therapy.
Observation:
- A case study involving a patient with idiopathic adult-onset generalized dystonia is presented.
- This patient's condition was unresponsive to all previous oral therapies.
Findings:
- Intrathecal baclofen therapy was administered to the patient.
- The treatment resulted in dramatic improvements in functional abilities.
- Chronic pain resolved, and the patient showed better scores on the dystonia scale.
Implications:
- Intrathecal baclofen therapy is a viable and effective treatment for refractory generalized dystonia.
- This therapeutic option can significantly enhance quality of life for patients with severe dystonia.
- Further research into baclofen's efficacy in movement disorders is warranted.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
04:41Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Alterations in Muscle Tone ll